Isolation and structure characterization of related impurities in etimicin intermediate P1 by LC/ESI-MS(n) and NMR.
Yuanchao Wang,Zhijie Zhang,Lingyun Wu,Xiaoqi Zhang,Hao Wang,Wencai Ye,Ping Li
DOI: https://doi.org/10.1016/j.jpba.2014.04.024
IF: 3.571
2014-01-01
Journal of Pharmaceutical and Biomedical Analysis
Abstract:Etimicin intermediate 3,2″,6″-N,N,N-triacetyl gentamicin C1a (P1), is a key intermediate of etimicin, which is a semi-synthetic aminoglycoside antibiotic effective to both gram-positive and gram-negative bacteria infections. Four major related impurities of P1 were detected by HPLC-ELSD and ESI-MS(n) methods. Weakly acidic cation exchange resin, CM-sephadex and silica gel column chromatography were used for the isolation and purification of four major impurities. By means of ESI-MS(n) and NMR analysis, related impurities were characterized as 3,2″-N,N-diacetyl gentamicin C1a (1), 3,2″,6″-N,N,N-triacetyl gentamicin C2b (2), 2″-N-acetyl gentamicin C1a (3), and 2″,6″-N,N-diacetyl gentamicin C1a (4). Impurities 1, 2, 4 are novel compounds and the NMR data of these isolates were first reported in this paper. The possible mechanism for the formation of these impurities is also discussed.